When it comes to MS treatment, what’s important to you?

If you're starting or switching treatment, there are many things to consider. Learn more about OCREVUS as an option, and talk to your doctor about whether it may be right for you.

OCREVUS® (ocrelizumab) at a glance

Compared with REBIF® in RMS and placebo in PPMS. REBIF® is a registered trademark of EMD Serono, Inc.

§Data on file. Genentech, Inc. March 2020

Based on Symphony Health Association data July 2017 through April 2020.

See why Misti chose OCREVUS:

Select Important Safety Information

OCREVUS can cause infusion reactions that can be serious and require you to be hospitalized. You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction. Tell your healthcare provider or nurse if you experience any reactions. Please visit Safety & Side Effects for more information.

When it comes to a treatment schedule, you have options.

As you and your doctor consider what treatment is right for you, it may help to know how other MS therapies are administered. This is not a complete list of all the possible treatments for MS. The comparison pertains only to differences in dosing and administration and should not be considered a comparison of efficacy or safety. For more information, talk to your healthcare provider.

Top 5 FDA-approved MS treatments for patients starting or switching to a new MS treatment; October 2018–May 2019 Symphony Health average prescriber-based data.

Trademarks are the property of their respective owners.

How does OCREVUS treat MS?

MS is caused by your immune system attacking the myelin surrounding the nerves in your brain. It is thought that specific types of B cells and T cells in your body are drivers of the attack. B cells play a central role in MS development as they activate the immune system in multiple ways, which includes recruiting T cells to attack neurons.

Until recently, scientists have focused on T cells as a primary target in treating MS. Many scientists now agree that both B cells and T cells play important roles.

OCREVUS works differently.

The exact way OCREVUS works is not fully known. It is believed that OCREVUS works by targeting specific types of B cells. As with any treatment, it's important to talk with your doctor to determine if OCREVUS is right for you.

Proven to be effective in the treatment of RMS and PPMS

When it comes to MS treatments, what matters most is results. Read more about the safety profile of OCREVUS and what OCREVUS has shown in clinical trials.

Results in Relapsing Multiple Sclerosis (RMS)

See how OCREVUS has been proven to be effective for the treatment of relapsing multiple sclerosis (RMS).

Results in Primary Progressive MS (PPMS)

OCREVUS IS THE ONLY FDA-approved treatment for primary progressive multiple sclerosis (PPMS).

Important Safety Information

Before starting any new treatment, it's important to review possible side effects and potential risks with your doctor, so together, you can decide if it is right for you.

KODY, an MS patient, using OCREVUS® since 2017

Let’s talk about the infusion experience

Your first dose will be split between 2 treatments for a total of 3 treatments your first year. Your treatment may be given at an infusion center, your doctor's office, or at home depending on what you and your doctor decide is right for you.